Literature DB >> 9430379

Posttranslational modification of proteins with fatty acids in platelets.

L Muszbek1, E Rácz, M Laposata.   

Abstract

Direct modification of proteins by fatty acid can occur as cotranslational N-myristoylation of an N-terminal glycine residue or as posttranslational thioesterification of cysteine residue(s). Platelets provide an excellent model system for studying the posttranslational type of modification in the absence of active protein synthesis and in the absence of protein synthesis-related protein modifications with lipids. Using this model system it was shown that thioesterification of proteins with fatty acid is less specific for palmitate than it was thought earlier and that other saturated, mono- and even polyunsaturated long chain fatty acids can also participate. The chain length and the extent of unsaturation of the protein-linked fatty acid moiety can, very likely, modulate hydrophobic protein-membrane lipid and protein-protein interactions. CD9, HLA class I glycoprotein, glycoproteins Ib, IX and IV, P-selectin and alpha subunits of G proteins have been demonstrated unequivocally as S-fatty acid acylated platelet proteins.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9430379     DOI: 10.1016/s0952-3278(97)90411-7

Source DB:  PubMed          Journal:  Prostaglandins Leukot Essent Fatty Acids        ISSN: 0952-3278            Impact factor:   4.006


  3 in total

1.  Proteomic analysis of palmitoylated platelet proteins.

Authors:  Louisa Dowal; Wei Yang; Michael R Freeman; Hanno Steen; Robert Flaumenhaft
Journal:  Blood       Date:  2011-08-02       Impact factor: 22.113

2.  Response to "Platelets proteomics in transfusion medicine: a reality with challenging but promising future".

Authors:  Bahram Alamdary Badlou; Farhad Rezaee
Journal:  Blood Transfus       Date:  2012-11-20       Impact factor: 3.443

3.  Relationship between platelet phospholipid FA and mean platelet volume in healthy men.

Authors:  Duo Li; Alan Turner; Andrew J Sinclair
Journal:  Lipids       Date:  2002-09       Impact factor: 1.880

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.